Who Generates More Revenue? Perrigo Company plc or Bausch Health Companies Inc.

Bausch Health leads in revenue over Perrigo from 2014-2023.

__timestampBausch Health Companies Inc.Perrigo Company plc
Wednesday, January 1, 201482635000004060800000
Thursday, January 1, 2015104988000004603900000
Friday, January 1, 201696740000005280600000
Sunday, January 1, 201787240000004946200000
Monday, January 1, 201883800000004731700000
Tuesday, January 1, 201986010000004837400000
Wednesday, January 1, 202080270000005063300000
Friday, January 1, 202184340000004138700000
Saturday, January 1, 202281240000004451600000
Sunday, January 1, 202387570000004655600000
Loading chart...

In pursuit of knowledge

Revenue Showdown: Perrigo vs. Bausch Health

In the competitive landscape of the pharmaceutical industry, revenue generation is a key indicator of a company's market position. From 2014 to 2023, Bausch Health Companies Inc. consistently outperformed Perrigo Company plc in terms of revenue. Bausch Health's revenue peaked in 2015, reaching approximately 10.5 billion, while Perrigo's highest revenue was around 5.3 billion in 2016. Over the decade, Bausch Health's average annual revenue was nearly double that of Perrigo, highlighting its stronger market presence. Despite fluctuations, Bausch Health maintained a steady lead, with its revenue in 2023 being about 88% higher than Perrigo's. This trend underscores Bausch Health's resilience and strategic positioning in the market. As the industry evolves, these insights provide a glimpse into the financial dynamics shaping the future of these pharmaceutical giants.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025